Neuphoria Therapeutics Inc (NEUP) insider trading
Every open-market stock purchase and sale by Neuphoria Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $3.3M over the last 12 months (1 buy).
- Last insider buy: Lynx1 Capital Management LP (10% owner), $3.3M, 11 months ago.
Last 12 months: insiders bought $3.3M (1 buy) and sold $0 (0 sales). Last close $4.49 on Jun 4, 2026.
Recent NEUP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 20, 2026 | Alan Fisher (Director) | Bought (not open market) | — |
| Jan 20, 2026 | Peter Miles Winston Davies (Director) | Bought (not open market) | — |
| Jan 20, 2026 | Jane Ryan (Director) | Bought (not open market) | — |
| Jan 20, 2026 | David Ian Wilson (Director) | Bought (not open market) | — |
| Oct 21, 2025 | Lynx1 Capital Management LP (10% owner) | Bought | $3.3M |
Who's trading NEUP
- Peter Miles Winston Davies, Director: other filings, last Jan 20, 2026
- Alan Fisher, Director: other filings, last Jan 20, 2026
- Jane Ryan, Director: other filings, last Jan 20, 2026
- David Ian Wilson, Director: other filings, last Jan 20, 2026
- Lynx1 Capital Management LP, 10% owner: bought $3.3M (1 buy), last Oct 21, 2025
Get free alerts when an insider at Neuphoria Therapeutics Inc files a new trade →